EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

EYA4 reduces chemosensitivity of osteosarcoma to doxorubicin through DNA damage repair

Wei Heng, Tianfu Wang, Feilong Wei, Fan Yang, Chaobo Chen, Zhe Yu, Mingrui Du, Jixian Qian, Chengpei Zhou

Biochemical Pharmacology · 2024

DOI: 10.1016/j.bcp.2024.116366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Wei Heng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Tangdu Hospital, Air Force Military Medical University, Xi'an 710038, China. Hauptthemen laut MEDLINE: Doxorubicin, Osteosarcoma, Drug Resistance, Neoplasm, DNA Repair. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies have demonstrated that Eyes Absent 4 (EYA4) influences the proliferation and migration of tumor cells. Notably, studies have established that EYA4 can also limit tumor sensitivity to chemotherapeutic agents. The objective of this study was to investigate the effect of EYA4 in conferring drug resistance in osteosarcoma (OS). Bioinformatics, histological, and cellular analyses revealed that the expression level of EYA4 was higher in OS tissues than in healthy tissues/cells and in resistant tissues/cells compared with sensitive tissues/cells. In vitro and in vivo experiments demonstrated that EYA4 knockdown increased the sensitivity of OS to doxorubicin (DOX). Conversely, overexpression of EYA4 decreased the sensitivity of OS to DOX. Exploration of the resistance mechanism exposed that EYA4 facilitates DNA double-strand break (DSB) repair, a typical mode of DNA damage repair (DDR). Subsequently, our findings indicated that EYA4 could directly interact with histone H2AX to activate the DDR pathway. Taken together, our observations indicated that EYA4 may serve as a target molecule for reversing drug resistance in OS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinOsteosarcomaDrug Resistance, NeoplasmDNA RepairBone NeoplasmsAntibiotics, AntineoplasticMice, NudeDNA DamageHumansAnimalsMiceCell Line, TumorTrans-ActivatorsFemaleMice, Inbred BALB CMaleXenograft Model Antitumor Assays

Stichwörter der Autor:innen

ChemoresistanceDNA damage repairDoxorubicinEYA4Osteosarcoma

Substanzen

DoxorubicinEYA4 protein, humanAntibiotics, AntineoplasticTrans-Activators

Autor:innen und Institutionen

  • Department of Orthopedics, Tangdu Hospital, Air Force Military Medical University, Xi'an 710038, China.
  • Department of Orthopedics, Tangdu Hospital, Air Force Military Medical University, Xi'an 710038, China; Western Theater Command Air Force Hospital, Chengdu 610065, China. Electronic address: mirrors_du@163.com.
  • Department of Orthopedics, Tangdu Hospital, Air Force Military Medical University, Xi'an 710038, China. Electronic address: pasmiss2012@163.com.
  • Department of Orthopedics, Tangdu Hospital, Air Force Military Medical University, Xi'an 710038, China. Electronic address: zhoucpei@fmmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Heng, W., Wang, T., Wei, F., Yang, F., Chen, C., Yu, Z., Du, M., Qian, J., & Zhou, C. (2024). EYA4 reduces chemosensitivity of osteosarcoma to doxorubicin through DNA damage repair. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116366

Vancouver

Heng W, Wang T, Wei F, Yang F, Chen C, Yu Z, et al. EYA4 reduces chemosensitivity of osteosarcoma to doxorubicin through DNA damage repair. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116366

BibTeX
@article{Heng2024,
  author = {Heng, Wei and Wang, Tianfu and Wei, Feilong and Yang, Fan and Chen, Chaobo and Yu, Zhe and Du, Mingrui and Qian, Jixian and Zhou, Chengpei},
  title = {EYA4 reduces chemosensitivity of osteosarcoma to doxorubicin through DNA damage repair},
  journal = {Biochemical Pharmacology},
  year = {2024},
  doi = {10.1016/j.bcp.2024.116366}
}
Kostenlos starten →